Abstract |
On May 1990, we began a treatment protocol for testicular stage I nonseminomatous cancer, with one chemotherapy cycle consisting of a cisplatin based combination of drugs. Until July 1996 we had admitted 18 patients, presenting five of them embryonal carcinoma and three yolk sac tumors. So far, with a median follow-up of 46.9 months, we had not relapses. 11 patients have normal long term semen analysis, with two achieving pregnancy. We believe this is acceptable alternative for treating stage I nonseminomatous cancer with scarce drugs adverse reactions. The convenience of selecting patients previous admittance, is discussed.
|
Authors | D Corti Ortíz, A Fonerón Burgos, L Troncoso Schifferli |
Journal | Actas urologicas espanolas
(Actas Urol Esp)
1997 Nov-Dec
Vol. 21
Issue 10
Pg. 961-3
ISSN: 0210-4806 [Print] Spain |
Vernacular Title | Tratamiento del cáncer testicular no seminoma etapa I con un ciclo de quimioterapia adyuvante. |
PMID | 9494159
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Bleomycin
- Vinblastine
- Cisplatin
|
Topics |
- Adult
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Bleomycin
(administration & dosage)
- Carcinoma, Embryonal
(drug therapy, pathology)
- Chemotherapy, Adjuvant
- Cisplatin
(administration & dosage)
- Endodermal Sinus Tumor
(drug therapy, pathology)
- Humans
- Male
- Neoplasm Staging
- Neoplasms, Germ Cell and Embryonal
(drug therapy, pathology)
- Testicular Neoplasms
(drug therapy, pathology)
- Vinblastine
(administration & dosage)
|